ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2025
Suspected canine primary lymph node mast cell tumor.
Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 8-year-old spayed female Chihuahua dog was diagnosed with a suspected primary mast cell tumor (MCT) of the left popliteal lymph node (LN). Physical examination, computed tomography, and focused hind-limb ultrasound failed to identify a primary integumentary MCT. Asymmetry of the ipsilateral medial iliac LN was identified on abdominal ultrasound. Surgical excision of the left popliteal and left medial iliac LN was completed without complication. Histologic assessment confirmed overt MCT effacement of both LN. Postoperatively, the dog received adjuvant chemotherapy (vinblastine and prednisone). The dog was alive 562 d after surgery, without evidence of disease recurrence. To the authors' knowledge, this is the first report in the veterinary literature documenting a suspected canine primary LN MCT. Key clinical message: Albeit rare, primary LN MCT should be a differential diagnosis for lymphadenopathy in the absence of a primary integumentary tumor.
Indexed as
Identifiers
41030425PMC12477740What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.